Long

OPGN Idea

Might be time to revisit OPGN, Chart loos great and company should be expecting FDA approval
of their product relatively soon from what I'm reading.
All JMO please DYODD. I am NOT a financial advisor.
Fundamental AnalysisTechnical IndicatorsOPGNTrend Analysis

Disclaimer